PLYMOUTH MEETING, Pa., Oct. 27, 2025 /PRNewswire/ — INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancers, and infectious diseases, today announced that its third quarter 2025 financial results will be released after the market close on November 10, 2025. Following the release,… Continue reading INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025
Tag: Financial Results
QYOU Media Subsidiary Chatterbox Technologies Reports Record Results
Strongest Revenue in History Achieved for First Half FY 2025-26 Supporting Strong IPO MUMBAI, India and TORONTO, Oct. 27, 2025 /PRNewswire/ – QYOU Media Inc., (TSXV: QYOU) (OTCQB: QYOUF), announced that its India subsidiary, ChatterBox Technologies Limited, has reported record financial results for the first half year ended September 30, 2025, demonstrating strong performance supporting its successful Initial Public Offering… Continue reading QYOU Media Subsidiary Chatterbox Technologies Reports Record Results
ADC Therapeutics to Present at November Investor Conferences
LAUSANNE, Switzerland, Oct. 27, 2025 /PRNewswire/ — ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced participation in three upcoming investor conferences in November: Stephens Biotechnology Virtual Fireside Chats 2025 Date: November 3, 2025 Presentation Time: 12:00 p.m. ET Format: Fireside Chat Speaker:… Continue reading ADC Therapeutics to Present at November Investor Conferences
ISX Financial EU PLC Appoints Group CFO Ajay Treon to the Board of Directors as Executive Director
NICOSIA, Cyprus, Oct. 27, 2025 /PRNewswire/ — ISX Financial EU Plc (“ISXX”), an EEA-authorised Electronic Money Institution and banktech provider of transactional banking and real-time payments across Europe and the UK, is pleased to announce the appointment of Mr. Ajay Treon, Group Chief Financial Officer, as an Executive Director on the Company’s Board of Directors.… Continue reading ISX Financial EU PLC Appoints Group CFO Ajay Treon to the Board of Directors as Executive Director
Daewoong Pharmaceutical: Third IDMC Reaffirms Safety of Bersiporocin and Recommends Continuation of Global Phase 2 Clinical Trial
Third Independent Data Monitoring Committee (IDMC) review confirms safety and continuation of the study 94 patients enrolled out of 102 planned across Korea and the U.S. Interim baseline characteristics to be presented at the 2025 KATRD International Conference SEOUL, South Korea, Oct. 27, 2025 /PRNewswire/ — Daewoong Pharmaceutical (Co-CEOs Seong-Soo Park and Chang-Jae Lee) announced that… Continue reading Daewoong Pharmaceutical: Third IDMC Reaffirms Safety of Bersiporocin and Recommends Continuation of Global Phase 2 Clinical Trial
Keurig Dr Pepper Reports Q3 2025 Results, Raises Full Year Net Sales Outlook and Reaffirms EPS Guidance for 2025
Q3 Results Driven by Strong Top-Line Growth Continued Momentum in U.S. Refreshment Beverages and Improving U.S. Coffee Trends Company Raises 2025 Constant Currency Net Sales Outlook and Reaffirms Adjusted EPS Guidance BURLINGTON, Mass. and FRISCO, Texas, Oct. 27, 2025 /PRNewswire/ — Keurig Dr Pepper Inc. (NASDAQ: KDP) today reported results for the third quarter of… Continue reading Keurig Dr Pepper Reports Q3 2025 Results, Raises Full Year Net Sales Outlook and Reaffirms EPS Guidance for 2025
Theravance Biopharma to Report Third Quarter 2025 Financial Results on November 10, 2025
DUBLIN, Oct. 27, 2025 /PRNewswire/ — Theravance Biopharma, Inc. (NASDAQ: TBPH) will report its third quarter 2025 financial results and provide a business update after market close on Monday, November 10, 2025. An accompanying conference call and simultaneous webcast will be hosted at 5:00 pm EST (2:00 pm PST / 10:00 pm GMT) that day. Conference… Continue reading Theravance Biopharma to Report Third Quarter 2025 Financial Results on November 10, 2025
West Synchrony™ Prefillable Syringe System Launches at CPHI: Redefining a system-level solution for drug delivery
The West Synchrony PFS system delivers a fully verified system-level solution designed specifically for biologics and vaccines. It sets a new standard in drug delivery by accelerating syringe selection through its comprehensive performance and regulatory data packages. “Leaders in drug development face pressures to meet milestones efficiently amid complex challenges, amongst them, selecting prefillable syringes.… Continue reading West Synchrony™ Prefillable Syringe System Launches at CPHI: Redefining a system-level solution for drug delivery
Ascletis to Present Study Results of ASC30 Oral Tablet, ASC30 Injection, and Combination of ASC31 and ASC47 at ObesityWeek® 2025
-Multiple posters being presented on Ascletis’ small molecule and peptide obesity programs -Full analysis of 28-day multiple ascending dose study of oral GLP-1R small molecule agonist ASC30 as a late-breaking poster as well as ASC30 once-monthly treatment formulation and once-quarterly maintenance formulation HONG KONG, Oct. 27, 2025 /PRNewswire/ — Ascletis Pharma Inc. (HKEX: 1672, “Ascletis”)… Continue reading Ascletis to Present Study Results of ASC30 Oral Tablet, ASC30 Injection, and Combination of ASC31 and ASC47 at ObesityWeek® 2025
Implantica presents the third quarter 2025 on October 31 at 15:00 CET
VADUZ, Liechtenstein, Oct. 27, 2025 /PRNewswire/ — Implantica AG (publ) invites investors to a presentation of the third quarter 2025 at 15:00 CET on October 31. The interim report for the third quarter will be published at 8:00 a.m. CET on the same day. The presentation will be in English via a webcast with teleconference:… Continue reading Implantica presents the third quarter 2025 on October 31 at 15:00 CET